U.S. markets closed
  • S&P Futures

    3,433.50
    -18.25 (-0.53%)
     
  • Dow Futures

    28,048.00
    -141.00 (-0.50%)
     
  • Nasdaq Futures

    11,617.50
    -46.00 (-0.39%)
     
  • Russell 2000 Futures

    1,622.20
    -13.40 (-0.82%)
     
  • Crude Oil

    39.18
    -0.67 (-1.68%)
     
  • Gold

    1,899.40
    -5.80 (-0.30%)
     
  • Silver

    24.39
    -0.29 (-1.18%)
     
  • EUR/USD

    1.1847
    -0.0021 (-0.18%)
     
  • 10-Yr Bond

    0.8410
    -0.0070 (-0.83%)
     
  • Vix

    27.55
    -0.56 (-1.99%)
     
  • GBP/USD

    1.3038
    -0.0001 (-0.00%)
     
  • USD/JPY

    104.8490
    +0.1590 (+0.15%)
     
  • BTC-USD

    13,096.62
    +75.73 (+0.58%)
     
  • CMC Crypto 200

    263.52
    +2.07 (+0.79%)
     
  • FTSE 100

    5,860.28
    +74.63 (+1.29%)
     
  • Nikkei 225

    23,518.39
    +1.80 (+0.01%)
     

UK mulling possible "human challenge" trials of COVID-19 vaccine

·1 min read

LONDON, Sept 23 (Reuters) - Britain said it was working with partners on the potential for "human challenge" clinical trials for a COVID-19 vaccine, where volunteers are deliberately infected with the virus to test the effectiveness of vaccine candidates, confirming an FT report.

"We are working with partners to understand how we might collaborate on the potential development of a COVID-19 vaccine through human challenge studies," a government spokeswoman said.

"These discussions are part of our work to research ways of treating, limiting and hopefully preventing the virus so we can end the pandemic sooner." (Reporting by Paul Sandle; editing by Stephen Addison)